Catalyst Wire Dossier Catalyst Wire Dossier

Fentanyl transdermal patch (JNS020 QD)

fentanyl · Janssen Pharmaceutical K.K.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fentanyl transdermal patch (JNS020 QD), covering 2013-05-21 to 2013-05-21. Get the full timeline:

Most recent: Clinical Trial Update: A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer Pain [Phase 2, Phase 3]

See pricing